4 completed, 1 terminated, 1 unknown. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Terminated 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Medroxyprogesterone: new trials by email Literature Review of Medroxyprogesterone trials Research Report on Medroxyprogesterone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol - Myelodysplastic Syndromes (MDS) | Phase 2 | Unknown | Prof. Janet Dunn | 120 | 2021-12-21 | 2023-10-03 |
| Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer Medroxyprogesterone progesterone acetate (MPA), Medroxyprogesterone with Cyclophosphamide + Methotrexate - Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer | Phase 2 | Completed | Indiana University | 30 | 2007-07-01 | 2023-10-16 |
| Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus Laboratory Biomarker Analysis, Medroxyprogesterone, Therapeutic Conventional Surgery - Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma | Phase 2 | Completed | Gynecologic Oncology Group | 75 | 2004-04-01 | 2016-04-11 |
| Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer medroxyprogesterone, ethinyl estradiol, norgestrel - Endometrial Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 52 | 2002-02-01 | 2013-05-03 |
| Alzheimer's Disease: Therapeutic Potential of Estrogen Transdermal estradiol, Medroxyprogesterone, Placebo Patch - Alzheimer Disease | Phase 2 / Phase 3 | Completed | University of Wisconsin, Madison | 42 | 2001-09-01 | 2018-08-23 |
| Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer medroxyprogesterone - Endometrial Cancer | Phase 2 | Terminated | Gynecologic Oncology Group | 360 | 1998-11-01 | 2013-06-10 |
Endometrial Neoplasms (2) · Alzheimer Disease (1) · Breast Neoplasms (1) · Myelodysplastic Syndromes (1)
Gynecologic Oncology Group (2) · Indiana University (1) · National Cancer Institute (NCI) (1) · Prof. Janet Dunn (1) · University of Wisconsin, Madison (1)
United States (5) · Norway (1) · United Kingdom (1)
Francisco A. R. Garcia, MD, MPH (1) · George L. Mutter, MD (1) · John P. Curtin, MD (1) · Karen Lu (1) · Kathy Miller, MD (1) · Richard Zaino (1) · Richard Zaino, MD (1) · Sanjay Asthana, MD (1)
R01AG017196 (1), U10CA027469 (1)